Gazanfer Belge

10PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 15, 2023
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.

Gazanfer Belge, Cansu Dumlupinar, Tim Nestler

|Aug 12, 2023
MicroRNA-371a-3p-The Novel Serum Biomarker in Testicular Germ Cell Tumors.

Tim Nestler, Justine Schoch, Gazanfer Belge

|Mar 04, 2023
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.

Klaus-Peter Dieckmann, Cansu Dumlupinar, Francesca Grobelny

|Nov 11, 2022
Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates-A Comprehensive Statistical Analysis.

Klaus-Peter Dieckmann, Hendrik Isbarn, Francesca Grobelny

|Nov 14, 2021
Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1.

Klaus-Peter Dieckmann, Cansu Dumlupinar, Arlo Radtke

|Apr 03, 2020
Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.

Manuel Regouc, Gazanfer Belge, Anja Lorch

Pageof 2

Frequent Collaborators

6 joint publications

Klaus-Peter Dieckmann

2 joint publications

João Lobo

2 joint publications

Tim Nestler

2 joint publications

Leendert H J Looijenga